<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

Oncology

Pharmacy    Oncology

Fulbright Sends O'Bryant to Nigeria

Dr. Cindy O’Bryant, PharmD, Professor in the Department of Clinical Pharmacy, received a Fulbright Specialist Program Scholar Award. A program of the U.S. Department of State, the Fulbright Specialist Program is a unique opportunity for U.S. academics and established professionals to engage in two to six-week, project-based exchanges at host institutions across the globe. On November 27, Dr. O’Bryant left the U.S. for Nigeria with other oncology pharmacists to share her knowledge and experience in cancer care to advance pharmacy oncology practice. She made time to answer questions before her trip about her award, what she expects from the field, and what she hopes to share with medical professionals in Nigeria.


Author Jordan Kellerman | Publish Date December 01, 2021
Full Story

School of Pharmacy In the News

NewsMedical

Study highlights importance of positive and negative selection in evolution of SARS-CoV-2 variants

news outletNewsMedical
Publish DateDecember 28, 2021

Krishna Mallela, PhD, and his team received press coverage for the lab’s work on SARS-CoV-2 variants, which focused on the study which highlights the importance of positive and negative selection in evolution of SARS-CoV-2 variants.

Full Story
Health.com

How the 2 New Pills for Treating COVID-19 Stack Up: Here's What Experts Say

news outletHealth.com
Publish DateDecember 28, 2021

Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.

Full Story
The Guardian

Covid pills are ‘very promising’ – but what are the challenges in using them?

news outletThe Guardian
Publish DateDecember 28, 2021

Peter Anderson, PharmD spoke with the Guardian about Paxlovid and molnupiravir, which were authorized by the FDA recently. Supplies of Paxlovid are limited while molnupiravir is less effective than hoped, but they are a very important step forward.

Full Story
Vanguard

US, NGO combat cancer, train 34 Nigerian oncology pharmacists

news outletVanguard
Publish DateDecember 14, 2021

Cindy O’Bryant, PharmD, had her recent Fulbright-sponsored work in Nigeria featured in a Vanguard article. The story examines the work being done to help reduce the high incidence of cancer, tackle late detection and improve general outlook of cancer in Nigeria.

Full Story